Company: RPTX
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030405
Chunk: 6

Company: Repare Therapeutics Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 15
Chunk 6
---
, 2023
     
    10-Q
     
    001-39335
     
    10.1
     
    May 9, 2023

    10.31†
     
    Fourth Amendment to Collaboration and License Agreement by and between the registrant and Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated May 12, 2023
     
    10-Q
     
    001-39335
     
    10.1
     
    August 9, 2023

    10.32+
     
    Form of Amendment to Executive Employment Agreement
     
    10-Q
     
    001-39335
     
    10.2
     
    August 9, 2023

    10.33†
     
    Fifth Amendment to Collaboration and License Agreement by and between the registrant and Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company dated March 14, 2024
     
    10-Q
     
    001-39335
     
    10.1 
     
    May 7, 2024

    10.34
     
    First Amendment to the Lease Agreement by and between the registrant, Repare Therapeutics Inc. and RREEF America REIT II Corp. PPP, dated August 26, 2024
     
    10-Q
     
    001-39335
     
    10.1
     
    November 7, 2024

    10.35
     
    Common Shares Sales Agreement, dated November 4, 2024, by and between Repare Therapeutics Inc. and TD Securities (USA) LLC
     
    10-Q
     
    001-39335
     
    10.2
     
    November 7, 2024

    19.1*
     
    Repare Therapeutics Inc. Insider Trading Policy

    21.1
     
    Subsidiaries of the registrant.
     
    S-1
     
    333-238822
     
    21.1
     
    May 29, 2020

    23.1*
     
    Consent of Ernst & Young LLP, an Independent Registered Public